Current price is less than the intrinsic value
Stock has been generating better return on equity than bank FD
Good time to consider, as stock is not in overbought zone
Stock not in ASM/GSM lists and not a lot of promoter holding is pledged
The company provides pharmaceutical development services. It provides contract manufacturing services for pharmaceutical industrialists and also focuses on product development and manufacturing capabilities in generic products.
Customise key metrics, see detailed forecasts, download stock data and more
1 month ago•Moneycontrol
1 month ago•Business Standard